The device is intended to provide relief from lumbar facet pain, restoring facet joint function while preserving native anatomy. It is a non-fusion and minimally invasive solution.
“The Glyder device fills a gap in the current care continuum between short-term treatments such as injections and irreversible procedures such as lumbar fusion, which requires advanced degeneration and comorbidities such as intervertebral disc disease or radiculopathy,” said Jim Bullock, president and CEO of Zyga Technology.
More articles devices:
Aurora Spine, MedAssets enter into contract
Stryker, Medtronic, Aurora Spine & more — 11 key notes
Zimmer net earnings up 7.9% ahead of Biomet acquisition completion — 10 points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
